Miura Global Management’s Accelerate Diagnostics AXDX Stock Holding History

Miura Global Management’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,000	Closed	-$4.57M	–	21
2018 Q1	$4.57M	Sell	20,000 -10,000	-33%	-$2.63M	0.91%	17
2017 Q4	$7.86M	Sell	30,000 -66,000	-69%	-$15.5M	2.28%	15
2017 Q3	$21.6M	Sell	96,000 -24,000	-20%	-$5.89M	5.62%	9
2017 Q2	$32.8M	Buy	120,000 +52,000	+76%	+$14.1M	7.19%	5
2017 Q1	$16.5M	Buy	68,000 +28,000	+70%	+$6.4M	3.01%	15
2016 Q4	$8.3M	Hold	40,000	–	–	1.81%	15
2016 Q3	$10.9M	Sell	40,000 -30,000	-43%	-$6.64M	1.19%	24
2016 Q2	$10.1M	Sell	70,000 -30,000	-30%	-$4.02M	1.08%	23
2016 Q1	$14.4M	Sell	100,000 -50,000	-33%	-$7.06M	0.99%	27
2015 Q4	$32.2M	Buy	150,000 +90,000	+150%	+$16.4M	1.92%	22
2015 Q3	$9.71M	Hold	60,000	–	–	0.53%	23
2015 Q2	$15.5M	Hold	60,000	–	–	0.94%	21
2015 Q1	$13.5M	Buy	60,000 +16,500	+38%	+$3.45M	0.81%	22
2014 Q4	$8.35M	Buy	43,500 +18,500	+74%	+$3.96M	0.63%	20
2014 Q3	$5.37M	Buy	+25,000	New	+$4.86M	0.43%	21

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Miura Global Management's AXDX Position: Q2 2018 in Review

Miura Global Management sold out of Accelerate Diagnostics (AXDX) in Q2 2018, closing a stake of 20,000 shares — an estimated $4.57M sold.

Miura Global Management first reported a position in AXDX in Q3 2014 and held it in 15 quarters. The position peaked at $32.8M in Q2 2017. 117 funds tracked by Wall St. Rank hold AXDX as of Q2 2018.

Miura Global Management reported no remaining Accelerate Diagnostics position as of Q2 2018 after selling out during the quarter.
Miura Global Management sold 20,000 Accelerate Diagnostics shares in Q2 2018, an estimated $4.57M.
Miura Global Management first reported a position in Accelerate Diagnostics in Q3 2014 and held it in 15 quarters.
Miura Global Management's Accelerate Diagnostics position peaked at $32.8M in Q2 2017.
117 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2018.

Based on Miura Global Management's 13F filing for Q2 2018, filed 14 Aug 2018.